The Economics of Healthcare

01 Health is not an ordinary product

Most goods can be postponed, compared, or abandoned when the price is too high. A heart attack cannot. That basic asymmetry gives healthcare a distinctive economic shape: people demand care partly when they are least able to shop, bargain, or absorb a surprise bill.

Health economics therefore asks more than whether a clinic is profitable. It asks how scarce labor, equipment, time, and money are allocated—and whether the allocation improves health. The central concepts are efficiency, which concerns output from resources, and equity, which concerns who receives care and who bears its costs.

02 The spending funnel

A healthcare bill is the endpoint of several layers. A person’s health need meets access rules; a clinician chooses among treatments; a hospital and supplier set or negotiate prices; insurers determine what is covered; and administrators translate the encounter into codes and payment. Two patients receiving similar care can face very different prices because they enter different contracts.

This is why national spending cannot be explained by “people consume too much” alone. Utilization matters, but so do prices, wages, market concentration, technology, and the rules that determine which services are profitable. An expensive system can spend more without producing proportionally better outcomes.

03 Insurance solves one problem and creates others

Insurance pools unpredictable medical costs so that a person does not need to save the full price of a rare catastrophe. That protection makes care financially possible, but it also separates the patient from the marginal price at the moment of treatment. Economists call the resulting incentive problem moral hazard: coverage can change behavior, though the phrase should not imply that people are acting irresponsibly.

There is an opposite problem before coverage begins. People who expect high medical costs are more likely to seek generous coverage, while healthier people may opt out if premiums rise. This adverse-selection pressure can destabilize a pool unless participation, subsidies, or risk adjustment keeps it broad.

04 Why prices vary so sharply

Healthcare prices are negotiated, not simply read from a universal menu. Hospitals with regional dominance can demand higher payment from insurers. Physicians, drug makers, device companies, and distributors each occupy positions in a chain with different bargaining power. A list price may be far above the amount an insurer actually pays, while an uninsured person can be billed close to the list.

Market power is not the only explanation. Emergency care, specialist scarcity, training costs, and quality differences can matter. But consolidation can weaken the comparison shopping that normally disciplines prices. When one system owns the hospital, clinics, and physician groups, “choice” may exist on paper while bargaining happens behind closed doors.

05 The public pays in several ways

Healthcare costs reach households through premiums, deductibles, copayments, taxes, employer compensation, and foregone wages. A low premium can be paired with a high deductible; a generous benefit can be financed through taxes or lower take-home pay. Focusing on one visible price hides the total transfer.

Public programs also reveal that healthcare is a political economy, not just a private transaction. Governments can pay directly, regulate prices, subsidize coverage, fund research, employ clinicians, or define minimum benefits. Each choice changes the distribution of risk and the bargaining position of patients and providers.

06 Efficiency is not the same as cutting

Reducing waste is valuable, but a cheaper system is not automatically a better one. Delayed diagnosis can lower this year’s spending and increase next year’s disability. Administrative simplicity can free clinical time; underpaying essential staff can create shortages. The relevant comparison is the health gained per dollar, not the dollar removed in isolation.

Cost-effectiveness analysis makes this explicit by comparing additional cost with additional health benefit. Its results depend on what counts as a benefit, whose perspective is used, and how uncertainty is handled. A society may reasonably choose a treatment that is not the cheapest if it protects people from severe loss or reflects a shared ethical commitment.

07 The economic question is ultimately institutional

Countries with different systems face the same underlying constraints: illness is uncertain, expertise is scarce, and resources are finite. Their outcomes differ because institutions decide how risk is pooled, how prices are negotiated, and how much care is treated as a right rather than a purchase.

The useful question is therefore not whether healthcare should be a “market” or a “government service” in the abstract. Every real system mixes markets, public budgets, professional rules, and social insurance. The serious work is to measure which combination expands access, controls avoidable prices, rewards effective care, and leaves people less afraid of getting sick.